Plain-English translation of NCT06412120 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing a medication called as a maintenance treatment for women with ovarian cancer. The medication works by blocking cancer cells' ability to repair their genes, which makes it harder for cancer to grow and spread. Researchers want to understand how this treatment works specifically in Black women and what factors might affect how well it works or what side effects occur.
Most ovarian cancer research has been done in primarily white populations, so doctors need better information about how this medication works in Black women and whether genetic or other factors might affect its safety and effectiveness in this group.
You likely qualify if…
You likely don't qualify if…
If you join, you would take as a pill for up to 24 cycles (each cycle is 28 days, so roughly 2 years of treatment). You'll have regular visits with the study team to check how you're doing, monitor for side effects, and do blood work. After you finish taking the medication, you'll continue to be followed for about one more year. In total, your participation would last about three years.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United States
Nigeria